Manage your formulary budget
Find generic entry opportunities
Anticipate generic drug launch
Proactively manage your pharmacy inventory
Deep knowledge on
small-molecule drugs and
the 110,000 global patents
Drug patents …
… from Kazakhstan to Kalamazoo
Flat-rate pricing for predictable budgeting
Short-term plans for project- or client-based billing
Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing
|Title:||Methods of treating dermatological disorders and inducing interferon biosynthesis with shorter durations of imiquimod therapy|
|Abstract:||Pharmaceutical formulations and methods for the topical and/or transdermal delivery of imiquimod, including creams, ointments and pressure-sensitive adhesive compositions to treat dermatological disorders, namely, viral infections, such as Type I or Type II Herpes simplex infections and genital and perianal warts, actinic keratosis and superficial basal cell carcinoma, and to induce interferon biosynthesis to achieve an antiviral effect, with shorter durations of therapy, than currently approved for imiquimod by the Food & Drug Administration ("FDA").|
|Inventor(s):||Gregory; Jefferson J. (Bristol, TN), Nordsiek; Michael T. (Wayne, PA)|
|Assignee:||Medicis Pharmaceutical Corporation (Scottsdale, AZ)|
1. A method for treating an external genital or perianal wart in a subject comprising: (a) applying a 3.75% w/w imiquimod composition to a dermatological area of the subject
having the wart; and (b) allowing the imiquimod composition to remain in contact with the dermatological area for a sufficient time following the application whereby an effective amount of the imiquimod composition penetrates the dermatological area;
and wherein the 3.75% w/w imiquimod composition is applied to the dermatological area of the subject once daily for up to 8 consecutive weeks or until clearance is observed, whichever occurs earlier, to treat the wart.
2. The method of claim 1, wherein imiquimod is the sole active pharmaceutical ingredient in the imiquimod composition applied to the dermatological area of the subject.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.